#26-69 Listing of subscription options of series TO2 in Byhmgard AB

Byhmgard AB's TO2 subscription options will begin trading on September 21, 2026, with the final trading day set for March 11, 2027. The company has issued 181,536,223 TO2 instruments, listed as BESS TO2 on the exchange. The notice is a routine listing update with limited expected market impact.

Analysis

This is a mechanical listing event rather than a fundamental catalyst; there is no basis to infer operating upside, valuation support, or directional equity demand from the commencement of TO2 trading alone. The unusually large warrant count relative to the likely free float creates a meaningful overhang: any intrinsic value in the warrants can translate into hedging activity and, eventually, equity issuance that caps rallies ahead of the exercise window.

The relevant near-term signal is liquidity, not price direction. During the first 1-3 weeks, monitor warrant turnover, bid-ask spreads, and the implied warrant/equity conversion relationship; thin trading would make quoted prices unreliable, while sustained warrant volume at a premium may indicate retail-driven speculation rather than informed fundamental demand. A sharp move in BESS without corresponding underlying-company disclosure should be treated cautiously.

Over the next 1-6 months, the key unknowns are exercise terms, dilution-adjusted share count, cash proceeds if exercised, and the company’s funding runway. If exercise proceeds are material relative to cash burn, the warrants could reduce near-term financing risk; if not, the structure may merely defer a subsequent discounted capital raise. No directional trade is warranted until these inputs are available.

Key Decisions for Investors

• No standalone position recommendation: treat BESS TO2 as a liquidity and capital-structure watch item, not a fundamental catalyst.
• Before considering any BESS exposure, obtain the TO2 strike price, subscription ratio, exercise dates, current basic and fully diluted share count, and latest cash-burn/runway disclosure; calculate the dilution-adjusted break-even versus the ordinary share.
• Set an alert for abnormal BESS TO2 volume or a warrant premium materially above theoretical value during September-October 2026; this would favor avoiding momentum-driven long exposure rather than chasing the move.
• Reassess 30-60 days before the March 2027 expiration window: only consider a tactical long in the ordinary shares if warrant exercise proceeds demonstrably extend funding runway by at least 12 months and management provides independently verifiable operating milestones.